P4–427: Evaluation of pro–inflammatory factors IL–1 and IL–6 as biomarkers in Alzheimer's disease using an intranasal cytokine model

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Alzheimer's & Dementia

• Publication date

  2006-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jalz.2006.05.2169
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Multi-Target Protective Effects of β-Caryophyllene (BCP) at the Intersection of Neuroinflammation and Neurodegeneration

  2025cites this paper
• Predictors of cognitive decline in older individuals without dementia: An updated meta‐analysis

  2023cites this paper
• The Effects of Modified Curcumin Preparations on Glial Morphology in Aging and Neuroinflammation

  2022cites this paper
• The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer’s Pathogenesis via Specific Pathways

  2022cites this paper
• Gelsemine, a natural alkaloid extracted from Gelsemium elegans Benth. alleviates neuroinflammation and cognitive impairments in Aβ oligomer-treated mice

  2020influential citation
• Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation

  2020cites this paper
• Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin

  2020cites this paper
• Suppressive effect of glycyrrhizic acid against lipopolysaccharide-induced neuroinflammation and cognitive impairment in C57 mice via toll-like receptor 4 signaling pathway

  2019cites this paper
• Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity

  2018cites this paper
• Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.

  2017cites this paper
• MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses

  2016cites this paper
• Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression

  2015cites this paper
• SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?

  2015cites this paper
• A rapid and sensitive HPLC-MS/MS method for determination of an aminopyridazine derived anti-neuroinflammatory agent (ZW14) in dog plasma: Application to a pharmacokinetic study.

  2015cites this paper
• Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis

  2015cites this paper
• Subneurotoxic copper(II)-induced NF-κB-dependent microglial activation is associated with mitochondrial ROS.

  2014cites this paper
• Quantitative assessment of microglial morphology and density reveals remarkable consistency in the distribution and morphology of cells within the healthy prefrontal cortex of the rat

  2014cites this paper
• Mast cells, glia and neuroinflammation: partners in crime?

  2014cites this paper
• Lysine (K)-deacetylase inhibitors: the real next step to neuropsychiatric and neurodegenerative disorders?

  2014cites this paper
• Upregulation of insulin‐like growth factor and interleukin 1β occurs in neurons but not in glial cells in the cochlear nucleus following cochlear ablation

  2013cites this paper
• Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.

  2013cites this paper
• Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator

  2013cites this paper
• THE S100B PROTEIN AS BIOMARKER FOR EARLY DIAGNOSIS OF FAT EMBOLISM SYNDROME.

  2013cites this paper
• Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

  2012cites this paper
• Resveratrol promotes neurotrophic factor release from astroglia

  2012cites this paper
• Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin‐induced damage

  2012cites this paper
• Microglia and mast cells: two tracks on the road to neuroinflammation

  2012cites this paper
• Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro

  2011cites this paper
• The roles of TNF in brain dysfunction and disease.

  2010cites this paper
• Gender differences in the long-term effects of chronic prenatal stress on the HPA axis and hypothalamic structure in rats.

  2010cites this paper
• Targeting p38 MAPK pathway for the treatment of Alzheimer's disease.

  2010cites this paper
• RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

  2010cites this paper
• Interleukin-1 Gene –511 CT Polymorphism and the Risk of Alzheimer’s Disease in a Polish Population

  2009cites this paper
• Rpida mejora cognitiva en la enfermedad de Alzheimer despus de administracin periespinal con etanercept.

  2009cites this paper
• Neutralization of interleukin‐1β modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice

  2009cites this paper
• The Role of Astrocyte Activation in Infantile Neuronal Ceroid Lipofuscinosis

  2009cites this paper
• Secretory phospholipase A2-IIA in Alzheimer's disease and inflammatory responses in astrocytes

  2009cites this paper
• en la enfermedad de Alzheimer después de administración periespinal con etanercept

  2009influential citation
• strocytic dysfunction : Insights on the role in neurodegeneration

  2009cites this paper
• S100B secretion is stimulated by IL-1beta in glial cultures and hippocampal slices of rats: Likely involvement of MAPK pathway.

  2009cites this paper
• The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease

  2009cites this paper
• Necrostatin-1 Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in Mice

  2008cites this paper
• Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.

  2008cites this paper
• Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction

  2008cites this paper
• Journal of Neuroinflammation Mcp-1-deficient Mice Show Reduced Neuroinflammatory Responses and Increased Peripheral Inflammatory Responses to Peripheral Endotoxin Insult

  2008cites this paper
• Blockade of chloride intracellular ion channel 1 stimulates Aβ phagocytosis

  2008cites this paper
• Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

  2008cites this paper
• Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury

  2008cites this paper
• Induction of interleukin‐1β by interleukin‐4 in lipopolysaccharide‐treated mixed glial cultures: microglial‐dependent effects

  2007cites this paper
• Expression of S100B during embryonic development of the mouse cerebellum

  2007cites this paper
• A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

  2007cites this paper
• Therapeutic approaches to inflammation in neurodegenerative disease

  2007cites this paper
• Protective effect of radicicol against LPS/IFN-gamma-induced neuronal cell death in rat cortical neuron-glia cultures.

  2007cites this paper
• Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.

  2007cites this paper
• Development of rodent in vivo models: Neuroinflammation and neurodegeneration relevant to Alzheimer's disease.

  2007cites this paper
• Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

  2007cites this paper
• Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation.

  2007cites this paper
• Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease

  2006cites this paper
• Journal of Neuroinflammation a Novel P38α Mapk Inhibitor Suppresses Brain Proinflammatory Cytokine Up-regulation and Attenuates Synaptic Dysfunction and Behavioral Deficits in an Alzheimer's Disease Mouse Model

  year unknowncites this paper